Clinical Trial Update: A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing salbutamol inhalers with two propellants (HFA-152a vs HFA-134a) in adults with mild asthma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Salbutamol (salbutamol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma, Mild Asthma | Phase 1 | Status: RECRUITING